168 related articles for article (PubMed ID: 11978135)
1. Topical corticosteroid-induced adrenocortical insufficiency: clinical implications.
Levin C; Maibach HI
Am J Clin Dermatol; 2002; 3(3):141-7. PubMed ID: 11978135
[TBL] [Abstract][Full Text] [Related]
2. Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse?
Güven A; Gülümser O; Ozgen T
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1173-82. PubMed ID: 18183788
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results of a pilot study investigating the potential of salivary cortisol measurements to detect occult adrenal suppression secondary to steroid nose drops.
Patel RS; Wallace AM; Hinnie J; McGarry GW
Clin Otolaryngol Allied Sci; 2001 Jun; 26(3):231-4. PubMed ID: 11437848
[TBL] [Abstract][Full Text] [Related]
4. Intranasal corticosteroids and adrenal suppression.
Bruni FM; De Luca G; Venturoli V; Boner AL
Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
[TBL] [Abstract][Full Text] [Related]
5. Adrenal and pituitary functions during long-term topical steroid therapy.
Hendrikse JC; Moolenaar AJ
Dermatologica; 1972; 144(3):179-86. PubMed ID: 4640839
[No Abstract] [Full Text] [Related]
6. Adrenal insufficiency and diabetes mellitus secondary to the use of topical corticosteroids for cosmetic purpose.
Sobngwi E; Lubin V; Ury P; Timsit FJ; Gautier JF; Vexiau P
Ann Endocrinol (Paris); 2003 Jun; 64(3):202-4. PubMed ID: 12910062
[TBL] [Abstract][Full Text] [Related]
7. [Symptomatic adrenal insufficiency secondary to the use of cutaneous topical steroids for skin-bleaching].
Sène D; Huong-Boutin DL; Thiollet M; Barete S; Cacoub P; Piette JC
Rev Med Interne; 2008 Dec; 29(12):1030-3. PubMed ID: 18586357
[TBL] [Abstract][Full Text] [Related]
8. Cushing's syndrome caused by topical steroid therapy for psoriasis.
Abma EM; Blanken R; De Heide LJ
Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
[TBL] [Abstract][Full Text] [Related]
9. Assessment of hair cortisol as a potential biomarker for possible adrenal suppression due to inhaled corticosteroid use in children with asthma: A retrospective observational study.
Smy L; Shaw K; Amstutz U; Staub M; Chaudhry S; Smith A; Carleton B; Koren G
Clin Biochem; 2018 Jun; 56():26-32. PubMed ID: 29673814
[TBL] [Abstract][Full Text] [Related]
10. [Secondary adrenal insufficiency due to exogenous glucocorticoid therapy].
Luca F; Taquet MC; Goichot B
Rev Med Interne; 2013 May; 34(5):324-7. PubMed ID: 23313326
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of strong topical corticosteroids.
Purdy MJ
Drugs; 1974; 8(1):70-7. PubMed ID: 4434866
[No Abstract] [Full Text] [Related]
12. Dynamic evaluation of adrenal hypofunction.
Nieman LK
J Endocrinol Invest; 2003; 26(7 Suppl):74-82. PubMed ID: 14604069
[TBL] [Abstract][Full Text] [Related]
13. Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis.
Philpott H; Dougherty MK; Reed CC; Caldwell M; Kirk D; Torpy DJ; Dellon ES
Aliment Pharmacol Ther; 2018 Apr; 47(8):1071-1078. PubMed ID: 29508432
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children.
Zöllner EW; Lombard CJ; Galal U; Hough FS; Irusen EM; Weinberg E
Pediatrics; 2012 Dec; 130(6):e1512-9. PubMed ID: 23147980
[TBL] [Abstract][Full Text] [Related]
15. The safe use of topical corticosteroids in children.
Raimer SS
Pediatr Ann; 2001 Apr; 30(4):225-9. PubMed ID: 11303439
[No Abstract] [Full Text] [Related]
16. [How to manage the interruption of a treatment with anti-inflammatory corticosteroids?].
Kuhn JM; Prévost G
Presse Med; 2014 Apr; 43(4 Pt 1):453-9. PubMed ID: 24613064
[TBL] [Abstract][Full Text] [Related]
17. Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone.
Paton J; Jardine E; McNeill E; Beaton S; Galloway P; Young D; Donaldson M
Arch Dis Child; 2006 Oct; 91(10):808-13. PubMed ID: 16556614
[TBL] [Abstract][Full Text] [Related]
18. Reference ranges and factors affecting the human corticotropin-releasing hormone test in preterm, very low birth weight infants.
Ng PC; Lam CW; Lee CH; Ma KC; Fok TF; Chan IH; Wong E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4621-8. PubMed ID: 12364445
[TBL] [Abstract][Full Text] [Related]
19. Adrenal Insufficiency Secondary to Abrupt Dose Reduction of Topical Corticosteroid Therapy after Starting Brodalumab for Psoriasis: A Case Report.
Yamane M; Hayashi H; Aoyama Y
Case Rep Dermatol; 2022; 14(1):77-83. PubMed ID: 35496509
[TBL] [Abstract][Full Text] [Related]
20. Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult.
Hindmarsh P
BMJ; 2002 May; 324(7345):1083. PubMed ID: 11993494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
